SGLT2 inhibitors, a class of diabetes drugs, may reduce the risk of Alzheimer’s, vascular dementia, and Parkinson’s disease, ...

A class of drugs used to treat diabetes has been linked to a 20% lower risk of dementia and Parkinson's disease. | ...

A first-of-its-kind study will use ultrasound and light therapies to investigate targeted treatment of Alzheimer’s disease, ...

New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.

Our sense of smell is more than just a way to enjoy food or detect dangers like fire. It turns out that changes in the ...

A first-of-its-kind study will investigate a potential 'cure' for Alzheimer's disease, dementia and Parkinson’s. The project, ...

A D.C.-area doctor calls a new study on people who pack in only one or two days of exercise a week “empowering.” ...